ACAD

ACADIA PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.25

EPS Forecast

$268.6

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
PAHCPhibro Animal Health CorpPBHPrestige Consumer Healthcare IncPCRXPacira Biosciences IncPTCTPtc Therapeutics IncQUREUniqure NvSAGESage Therapeutics IncUTHRUnited Therapeutics Corp